Renal Failure: A Modern Semiology for an Old Disease

 

 Buy Article Permissions and Reprints

Abstract

Chronic kidney disease (CKD) is a complex systemic disease that induces mineral metabolic dysfunction leading to bone fragility and tissue calcifications. Bone abnormalities in CKD can include increased bone turnover and resorption due to secondary hyperparathyroidism, decreased bone turnover and bone formation, defective bone mineralization, or a mixed pattern of these abnormalities. Other features of musculoskeletal involvement include synovial, tendon, and ligament thickening due to β2-microglobulin amyloidosis, soft tissue masses, or axial and peripheral arthropathies. The accurate assessment of bone involvement in early-stage CKD is crucial for the success of therapeutic interventions. We summarize the key semiologic features of bone abnormalities in CKD and review musculoskeletal complications as depicted by conventional radiography, computed tomography, magnetic resonance, and ultrasound imaging. We also discuss different experimental diagnostic approaches developed for the purpose of identifying changes in bone quality and structure in early-stage CKD.

• References

• 1 Eknoyan G, Lameire N, Barsoum R , et al. The burden of kidney disease: improving global outcomes. Kidney Int 2004; 66 (4) 1310-1314
  CrossrefPubMedGoogle Scholar
• 2 Moe S, Drüeke T, Cunningham J , et al. Kidney Disease: Improving Global Outcomes (KDIGO). Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 69 (11) 1945-1953
  CrossrefPubMedGoogle Scholar
• 3 Babayev R, Nickolas TL. Bone disorders in chronic kidney disease: an update in diagnosis and management. Semin Dial 2015; 28 (6) 645-653
  CrossrefPubMedGoogle Scholar
• 4 Malluche HH, Mawad HW, Monier-Faugere MC. Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Miner Res 2011; 26 (6) 1368-1376
  CrossrefPubMedGoogle Scholar
• 5 Kim SM, Long J, Montez-Rath M, Leonard M, Chertow GM. Hip fracture in patients with non-dialysis-requiring chronic kidney disease. J Bone Miner Res 2016; 5: 4
  PubMedGoogle Scholar
• 6 Kazama JJ, Matsuo K, Iwasaki Y, Fukagawa M. Chronic kidney disease and bone metabolism. J Bone Miner Metab 2015; 33 (3) 245-252
  CrossrefPubMedGoogle Scholar
• 7 Jamal SA, Nickolas TL. Bone imaging and fracture risk assessment in kidney disease. Curr Osteoporos Rep 2015; 13 (3) 166-172
  CrossrefPubMedGoogle Scholar
• 8 Vervloet MG, Massy ZA, Brandenburg VM , et al; CKD-MBD Working Group of ERA-EDTA. Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders. Lancet Diabetes Endocrinol 2014; 2 (5) 427-436
  PubMedGoogle Scholar
• 9 Bricker NS. On the pathogenesis of the uremic state. An exposition of the “trade-off hypothesis”. N Engl J Med 1972; 286 (20) 1093-1099
  CrossrefPubMedGoogle Scholar
• 10 Bauer W, Albright F, Aub JC. A case of osteitis fibrosa cystica (osteomalacia?) with evidence of hyperactivity of the parathyroid bodies. Metabolic Study II. J Clin Invest 1930; 8 (2) 229-248
  CrossrefPubMedGoogle Scholar
• 11 Massry SG, Bluestone R, Klinenberg JR, Coburn JW. Abnormalities of the musculoskeletal system in hemodialysis patients. Semin Arthritis Rheum 1975; 4 (4) 321-349
  CrossrefPubMedGoogle Scholar
• 12 Murphey MD, Sartoris DJ, Quale JL, Pathria MN, Martin NL. Musculoskeletal manifestations of chronic renal insufficiency. Radiographics 1993; 13 (2) 357-379
  CrossrefPubMedGoogle Scholar
• 13 Jensen PS, Kliger AS. Early radiographic manifestations of secondary hyperparathyroidism associated with chronic renal disease. Radiology 1977; 125 (3) 645-652
  CrossrefPubMedGoogle Scholar
• 14 Lim CY, Ong KO. Various musculoskeletal manifestations of chronic renal insufficiency. Clin Radiol 2013; 68 (7) e397-e411
  CrossrefPubMedGoogle Scholar
• 15 Rousselin B, Helenon O, Zingraff J , et al. Pseudotumor of the craniocervical junction during long-term hemodialysis. Arthritis Rheum 1990; 33 (10) 1567-1573
  CrossrefPubMedGoogle Scholar
• 16 Sundaram M, Joyce PF, Shields JB, Riaz MA, Sagar S. Terminal phalangeal tufts: earliest site of renal osteodystrophy findings in hemodialysis patients. AJR Am J Roentgenol 1979; 133 (1) 25-29
  CrossrefPubMedGoogle Scholar
• 17 Moe SM, Drüeke T, Lameire N, Eknoyan G. Chronic kidney disease-mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis 2007; 14 (1) 3-12
  CrossrefPubMedGoogle Scholar
• 18 Resnick D, Deftos LJ, Parthemore JG. Renal osteodystrophy: magnification radiography of target sites of absorption. AJR Am J Roentgenol 1981; 136 (4) 711-714
  CrossrefPubMedGoogle Scholar
• 19 Jevtic V. Imaging of renal osteodystrophy. Eur J Radiol 2003; 46 (2) 85-95
  CrossrefPubMedGoogle Scholar
• 20 Wittenberg A. The rugger jersey spine sign. Radiology 2004; 230 (2) 491-492
  CrossrefPubMedGoogle Scholar
• 21 Griffiths HJ, Ennis JT, Bailey G. Skeletal changes following renal transplantation. Radiology 1974; 113 (3) 621-626
  CrossrefPubMedGoogle Scholar
• 22 Katz AI, Hampers CL, Merrill JP. Secondary hyperparathyroidism and renal osteodystrophy in chronic renal failure. Analysis of 195 patients, with observations on the effects of chronic dialysis, kidney transplantation and subtotal parathyroidectomy. Medicine (Baltimore) 1969; 48 (5) 333-374
  CrossrefPubMedGoogle Scholar
• 23 Meema HE, Oreopoulos DG, Murray TM. Periosteal resorption and periosteal neostosis: comparison of normal subjects and renal failure patients on chronic ambulatory peritoneal dialysis using MOP-3 image analysis system and a grading method. Skeletal Radiol 1986; 15 (1) 14-20
  CrossrefPubMedGoogle Scholar
• 24 Parnell AP, Simpson W, Ward MK. Periosteal new bone formation in chronic renal failure. Clin Radiol 1989; 40 (5) 490-493
  CrossrefPubMedGoogle Scholar
• 25 Ritchie WG, Winney RJ, Davison AM, Robson JS. Periosteal new bone formation developing during haemodialysis for chronic renal failure. Br J Radiol 1975; 48 (572) 656-661
  CrossrefPubMedGoogle Scholar
• 26 Resnick D. Parathyroid disorders and renal osteodystrophy. In: Resnick D, , et al., eds. Diagnosis of Bone and Joint Disorders. 4th ed. Philadelphia, PA: Saunders; 2002: 2043-2111
  Google Scholar
• 27 Goldman AB, Lane JM, Salvati E. Slipped capital femoral epiphyses complicating renal osteodystrophy: a report of three cases. Radiology 1978; 126 (2) 333-339
  CrossrefPubMedGoogle Scholar
• 28 Fusaro M, Noale M, Viola V , et al; VItamin K Italian (VIKI) Dialysis Study Investigators. Vitamin K, vertebral fractures, vascular calcifications, and mortality: Vitamin K Italian (VIKI) dialysis study. J Bone Miner Res 2012; 27 (11) 2271-2278
  CrossrefPubMedGoogle Scholar
• 29 Hercz G, Pei Y, Greenwood C , et al. Aplastic osteodystrophy without aluminum: the role of “suppressed” parathyroid function. Kidney Int 1993; 44 (4) 860-866
  CrossrefPubMedGoogle Scholar
• 30 Kriegshauser JS, Swee RG, McCarthy JT, Hauser MF. Aluminum toxicity in patients undergoing dialysis: radiographic findings and prediction of bone biopsy results. Radiology 1987; 164 (2) 399-403
  CrossrefPubMedGoogle Scholar
• 31 Sundaram M, Dessner D, Ballal S. Solitary, spontaneous cervical and large bone fractures in aluminum osteodystrophy. Skeletal Radiol 1991; 20 (2) 91-94
  PubMedGoogle Scholar
• 32 Drüeke TB, Massy ZA. Changing bone patterns with progression of chronic kidney disease. Kidney Int 2016; 89 (2) 289-302
  CrossrefPubMedGoogle Scholar
• 33 Barreto FC, Barreto DV, Canziani ME , et al. Association between indoxyl sulfate and bone histomorphometry in pre-dialysis chronic kidney disease patients. J Bras Neurol 2014; 36 (3) 289-296
  PubMedGoogle Scholar
• 34 Coen G, Mazzaferro S, Ballanti P , et al. Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study. Nephrol Dial Transplant 1996; 11 (5) 813-819
  CrossrefPubMedGoogle Scholar
• 35 Fang Y, Ginsberg C, Seifert M , et al. CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder. J Am Soc Nephrol 2014; 25 (8) 1760-1773
  CrossrefPubMedGoogle Scholar
• 36 D'Haese PC, Couttenye MM, De Broe ME. Diagnosis and treatment of aluminium bone disease. Nephrol Dial Transplant 1996; 11 (Suppl. 03) 74-79
  CrossrefPubMedGoogle Scholar
• 37 Andreoli SP, Bergstein JM, Sherrard DJ. Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis. N Engl J Med 1984; 310 (17) 1079-1084
  CrossrefPubMedGoogle Scholar
• 38 Solal ME, Sebert JL, Boudailliez B , et al. Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients. J Clin Endocrinol Metab 1991; 73 (3) 516-524
  CrossrefPubMedGoogle Scholar
• 39 Van de Vyver FL, Visser WJ, D'Haese PC, De Broe ME. Iron overload and bone disease in chronic dialysis patients. Nephrol Dial Transplant 1990; 5 (9) 781-787
  CrossrefPubMedGoogle Scholar
• 40 Bucur RC, Panjwani DD, Turner L, Rader T, West SL, Jamal SA. Low bone mineral density and fractures in stages 3-5 CKD: an updated systematic review and meta-analysis. Osteoporos Int 2015; 26 (2) 449-458
  CrossrefPubMedGoogle Scholar
• 41 Ensrud KE, Lui LY, Taylor BC , et al; Osteoporotic Fractures Research Group. Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med 2007; 167 (2) 133-139
  CrossrefPubMedGoogle Scholar
• 42 Alem AM, Sherrard DJ, Gillen DL , et al. Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 2000; 58 (1) 396-399
  CrossrefPubMedGoogle Scholar
• 43 Dukas L, Schacht E, Stähelin HB. In elderly men and women treated for osteoporosis a low creatinine clearance of <65 ml/min is a risk factor for falls and fractures. Osteoporos Int 2005; 16 (12) 1683-1690
  CrossrefPubMedGoogle Scholar
• 44 Guglielmi G, Haslam J, DʼErrico F, Steiger P, Nasuto M. Comprehensive vertebral deformity and vertebral fracture assessment in clinical practice: intra- and inter-reader agreement of a clinical workflow tool. Spine 2013; 38 (26) 1676-1683
  CrossrefPubMedGoogle Scholar
• 45 Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009; 113 (113) S1-S130
  Google Scholar
• 46 Jamal SA, Hayden JA, Beyene J. Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis. Am J Kidney Dis 2007; 49 (5) 674-681
  CrossrefPubMedGoogle Scholar
• 47 Yenchek RH, Ix JH, Shlipak MG , et al. Health, Aging, and Body Composition Study. Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol 2012; 7 (7) 1130-1136
  CrossrefPubMedGoogle Scholar
• 48 Iimori S, Mori Y, Akita W , et al. Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients—a single-center cohort study. Nephrol Dial Transplant 2012; 27 (1) 345-351
  CrossrefPubMedGoogle Scholar
• 49 Jamal SA, Swan VJ, Brown JP , et al. Canadian Multicentre Osteoporosis Study Research Group. Kidney function and rate of bone loss at the hip and spine: the Canadian Multicentre Osteoporosis Study. Am J Kidney Dis 2010; 55 (2) 291-299
  CrossrefPubMedGoogle Scholar
• 50 Ketteler M, Elder GJ, Evenepoel P , et al. Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference. Kidney Int 2015; 87 (3) 502-528
  CrossrefPubMedGoogle Scholar
• 51 Malluche HH, Davenport DL, Cantor T, Monier-Faugere MC. Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis. Clin J Am Soc Nephrol 2014; 9 (7) 1254-1262
  CrossrefPubMedGoogle Scholar
• 52 West SL, Lok CE, Langsetmo L , et al. Bone mineral density predicts fractures in chronic kidney disease. J Bone Miner Res 2015; 30 (5) 913-919
  CrossrefPubMedGoogle Scholar
• 53 Drüeke TB. Foreword: extraskeletal calcifications in patients with chronic renal failure. Nephrol Dial Transplant 2002; 17 (2) 330-331
  CrossrefPubMedGoogle Scholar
• 54 Setiawati R, Di Chio F, Rahardjo P, Nasuto M, Dimpudus FJ, Guglielmi G. Quantitative assessment of abdominal aortic calcifications using lateral lumbar radiograph, dual-energy X-ray absorptiometry, and quantitative computed tomography of the spine. J Clin Densitom 2016; 19 (2) 242-249
  CrossrefPubMedGoogle Scholar
• 55 Gipstein RM, Coburn JW, Adams DA , et al. Calciphylaxis in man. A syndrome of tissue necrosis and vascular calcification in 11 patients with chronic renal failure. Arch Intern Med 1976; 136 (11) 1273-1280
  CrossrefPubMedGoogle Scholar
• 56 McGregor D, Burn J, Lynn K, Robson R. Rapid resolution of tumoral calcinosis after renal transplantation. Clin Nephrol 1999; 51 (1) 54-58
  PubMedGoogle Scholar
• 57 McKee PH, Liomba NG, Hutt MS. Tumoral calcinosis: a pathological study of fifty-six cases. Br J Dermatol 1982; 107 (6) 669-674
  CrossrefPubMedGoogle Scholar
• 58 Durant DM, Riley III LH, Burger PC, McCarthy EF. Tumoral calcinosis of the spine: a study of 21 cases. Spine 2001; 26 (15) 1673-1679
  CrossrefPubMedGoogle Scholar
• 59 Kokubun S, Ozawa H, Sakurai M, Tanaka Y. Tumoral calcinosis in the upper cervical spine: a case report. Spine 1996; 21 (2) 249-252
  CrossrefPubMedGoogle Scholar
• 60 Matsukado K, Amano T, Itou O, Yuhi F, Nagata S. Tumoral calcinosis in the upper cervical spine causing progressive radiculomyelopathy—case report. Neurol Med Chir (Tokyo) 2001; 41 (8) 411-414
  CrossrefPubMedGoogle Scholar
• 61 Chang CC, Sung CC, Hsia CC, Lin SH. Uremic tumoral calcinosis causing atlantoaxial subluxation and spinal cord compression in a patient on continuous ambulatory peritoneal dialysis. Int Urol Nephrol 2013; 45 (5) 1511-1516
  CrossrefPubMedGoogle Scholar
• 62 Cofan F, García S, Combalia A, Campistol JM, Oppenheimer F, Ramón R. Uremic tumoral calcinosis in patients receiving longterm hemodialysis therapy. J Rheumatol 1999; 26 (2) 379-385
  PubMedGoogle Scholar
• 63 Hamada J, Tamai K, Ono W, Saotome K. Uremic tumoral calcinosis in hemodialysis patients: clinicopathological findings and identification of calcific deposits. J Rheumatol 2006; 33 (1) 119-126
  PubMedGoogle Scholar
• 64 Baek D, Lee SE, Kim WJ , et al. Greater trochanteric pain syndrome due to tumoral calcinosis in a patient with chronic kidney disease. Pain Physician 2014; 17 (6) E775-E782
  PubMedGoogle Scholar
• 65 Christidou F, Bamichas G, Stangou M, Natse T, Kalpakidis V, Sombolos K. Tumoral calcinosis inducing systemic inflammatory response in a hemodialysis patient. Nephron 2002; 92 (2) 497-498
  CrossrefPubMedGoogle Scholar
• 66 García S, Cofán F, Fernández RP, Sala P, Oppenheimer F. Uremic tumoral calcinosis of the foot mimicking infection. Foot Ankle Int 2002; 23 (3) 260-263
  CrossrefPubMedGoogle Scholar
• 67 Cribier B, Grosshans E. Cutaneous calcinosis [in French]. Ann Dermatol Venereol 1992; 119 (2) 151-168
  PubMedGoogle Scholar
• 68 Ben Taarit C, el Younsi F, Turki S, Mestiri M, Zlitni M, Ben Maïz H. La calcinose tumorale des hémodialysés: étude anatomoclinique: à propos de trois cas. Nephrologie 2001; 22 (7) 349-352
  PubMedGoogle Scholar
• 69 Hodnett P, Moore M, Kinsella S, Kelly D, Plant WD, Maher MM. Radiological features of progressive tumoral calcinosis in chronic renal failure. Australas Radiol 2007; 51 (Spec No): B115-B118
  CrossrefPubMedGoogle Scholar
• 70 Remy-Leroux V, Reguiaï Z, Labrousse AL, Zakine EM, Clavel P, Bernard P. Tumorous calcinosis in hemodialysis: anatomo-clinical study apropos of 3 cases [in French]. Ann Dermatol Venereol 2009; 136 (4) 350-354
  CrossrefPubMedGoogle Scholar
• 71 Meltzer CC, Fishman EK, Scott Jr WW. Tumoral calcinosis causing bone erosion in a renal dialysis patient. Clin Imaging 1992; 16 (1) 49-51
  CrossrefPubMedGoogle Scholar
• 72 Kuzela DC, Huffer WE, Conger JD, Winter SD, Hammond WS. Soft tissue calcification in chronic dialysis patients. Am J Pathol 1977; 86 (2) 403-424
  PubMedGoogle Scholar
• 73 Fukuda K, Yamamoto H. Dialysis-related amyloidosis. Semin Musculoskelet Radiol 2001; 5 (2) 113-119
  Article in Thieme ConnectPubMedGoogle Scholar
• 74 Masakane I, Nakai S, Ogata S , et al. An overview of regular dialysis treatment in Japan (as of 31 December 2013). Ther Apher Dial 2015; 19 (6) 540-574
  CrossrefPubMedGoogle Scholar
• 75 Kiss E, Keusch G, Zanetti M , et al. Dialysis-related amyloidosis revisited. AJR Am J Roentgenol 2005; 185 (6) 1460-1467
  CrossrefPubMedGoogle Scholar
• 76 Danesh F, Ho LT. Dialysis-related amyloidosis: history and clinical manifestations. Semin Dial 2001; 14 (2) 80-85
  CrossrefPubMedGoogle Scholar
• 77 Blanco P, Viallard JF, Bonotto B, Buy E, Pellegrin JL, Leng B. Joint involvement in AL amyloidosis [in French]. Ann Med Interne (Paris) 1999; 150 (4) 287-293
  PubMedGoogle Scholar
• 78 Lanteri M, Ptasznik R, Constable L, Dawborn JK. Ultrasound changes in the wrist and hand in hemodialysis patients. Clin Nephrol 1997; 48 (6) 375-380
  PubMedGoogle Scholar
• 79 Takahashi T, Kato A, Ikegaya N , et al. Ultrasound changes of the carpal tunnel in patients receiving long-term hemodialysis: a cross-sectional and longitudinal study. Clin Nephrol 2002; 57 (3) 230-236
  CrossrefPubMedGoogle Scholar
• 80 Cardinal E, Buckwalter KA, Braunstein EM, Raymond-Tremblay D, Benson MD. Amyloidosis of the shoulder in patients on chronic hemodialysis: sonographic findings. AJR Am J Roentgenol 1996; 166 (1) 153-156
  CrossrefPubMedGoogle Scholar
• 81 Jadoul M, Malghem J, vande Berg B, van Ypersele de Strihou C. Ultrasonography of joint capsules and tendons in dialysis-related amyloidosis. Kidney Int Suppl 1993; 41: S106-S110
  PubMedGoogle Scholar
• 82 Nessi R, Anelli A, Brancaccio D, Raiteri R, Chiara Bossi M, Uslenghi C. Use of echography for the diagnosis of joint amyloidosis in dialyzed patients [in French]. J Radiol 1991; 72 (1) 17-22
  PubMedGoogle Scholar
• 83 Sommer R, Valen GJ, Ori Y , et al. Sonographic features of dialysis-related amyloidosis of the shoulder. J Ultrasound Med 2000; 19 (11) 765-770
  CrossrefPubMedGoogle Scholar
• 84 Decourt A, Gondouin B, Delaroziere JC , et al. Trends in survival and renal recovery in patients with multiple myeloma or light-chain amyloidosis on chronic dialysis. Clin J Am Soc Nephrol 2016; 11 (3) 431-441
  CrossrefPubMedGoogle Scholar
• 85 Ross LV, Ross GJ, Mesgarzadeh M, Edmonds PR, Bonakdarpour A. Hemodialysis-related amyloidomas of bone. Radiology 1991; 178 (1) 263-265
  CrossrefPubMedGoogle Scholar
• 86 Theodorou DJ, Theodorou SJ, Resnick D. Imaging in dialysis spondyloarthropathy. Semin Dial 2002; 15 (4) 290-296
  CrossrefPubMedGoogle Scholar
• 87 Escobedo EM, Hunter JC, Zink-Brody GC, Andress DL. Magnetic resonance imaging of dialysis-related amyloidosis of the shoulder and hip. Skeletal Radiol 1996; 25 (1) 41-48
  CrossrefPubMedGoogle Scholar
• 88 Kuntz D, Naveau B, Bardin T, Drueke T, Treves R, Dryll A. Destructive spondylarthropathy in hemodialyzed patients. A new syndrome. Arthritis Rheum 1984; 27 (4) 369-375
  CrossrefPubMedGoogle Scholar
• 89 Cotten A, Flipo RM, Boutry N , et al. Natural course of erosive arthropathy of the hand in patients undergoing hemodialysis. Skeletal Radiol 1997; 26 (1) 20-26
  CrossrefPubMedGoogle Scholar
• 90 M'Bappé P, Grateau G. Manifestations ostéoarticulaires de l'amylose. EMC – Appareil locomoteur 2015; 10 (2) 1-9
  PubMedGoogle Scholar
• 91 Javier RM, Moulin B. Complications ostéoarticulaires des hémodialysés (hors ostéodystrophie rénale). EMC – Appareil locomoteur 2009; 4 (4) 1-11
  PubMedGoogle Scholar
• 92 Shiota E, Tsuchiya K, Yamaoka K, Kawano O. Spontaneous major tendon ruptures in patients receiving long-term hemodialysis. Clin Orthop Relat Res 2002; (394) 236-242
  PubMedGoogle Scholar
• 93 Moorthi RN, Moe SM. Recent advances in the noninvasive diagnosis of renal osteodystrophy. Kidney Int 2013; 84 (5) 886-894
  CrossrefPubMedGoogle Scholar
• 94 Schellinger D, Lin CS, Lim J, Hatipoglu HG, Pezzullo JC, Singer AJ. Bone marrow fat and bone mineral density on proton MR spectroscopy and dual-energy X-ray absorptiometry: their ratio as a new indicator of bone weakening. AJR Am J Roentgenol 2004; 183 (6) 1761-1765
  CrossrefPubMedGoogle Scholar
• 95 Pansini V, Monnet A, Salleron J, Hardouin P, Cortet B, Cotten A. 3.  Tesla (1) H MR spectroscopy of hip bone marrow in a healthy population, assessment of normal fat content values and influence of age and sex. J Magn Reson Imaging 2014; 39 (2) 369-376
  CrossrefPubMedGoogle Scholar
• 96 Hu HH, Kan HE. Quantitative proton MR techniques for measuring fat. NMR Biomed 2013; 26 (12) 1609-1629
  CrossrefPubMedGoogle Scholar
• 97 Bley TA, Wieben O, François CJ, Brittain JH, Reeder SB. Fat and water magnetic resonance imaging. J Magn Reson Imaging 2010; 31 (1) 4-18
  CrossrefPubMedGoogle Scholar
• 98 Moorthi RN, Fadel W, Eckert GJ, Ponsler-Sipes K, Moe SM, Lin C. Bone marrow fat is increased in chronic kidney disease by magnetic resonance spectroscopy. Osteoporos Int 2015; 26 (6) 1801-1807
  CrossrefPubMedGoogle Scholar
• 99 Leonard MB. A structural approach to skeletal fragility in chronic kidney disease. Semin Nephrol 2009; 29 (2) 133-143
  CrossrefPubMedGoogle Scholar
• 100 Nickolas TL, Stein E, Cohen A , et al. Bone mass and microarchitecture in CKD patients with fracture. J Am Soc Nephrol 2010; 21 (8) 1371-1380
  CrossrefPubMedGoogle Scholar
• 101 Trombetti A, Stoermann C, Chevalley T , et al. Alterations of bone microstructure and strength in end-stage renal failure. Osteoporos Int 2013; 24 (5) 1721-1732
  CrossrefPubMedGoogle Scholar
• 102 Link TM, , Saborowski, Kisters K. , et al. Changes in calcaneal trabecular bone structure assessed with high-resolution MR imaging in patients with kidney transplantation. Osteoporos Int 2002; 13 (2) 119-129
  CrossrefPubMedGoogle Scholar
• 103 Wehrli FW, Leonard MB, Saha PK, Gomberg BR. Quantitative high-resolution magnetic resonance imaging reveals structural implications of renal osteodystrophy on trabecular and cortical bone. J Magn Reson Imaging 2004; 20 (1) 83-89
  CrossrefPubMedGoogle Scholar
• 104 Jamal S, Cheung AM, West S, Lok C. Bone mineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease. Osteoporos Int 2012; 23 (12) 2805-2813
  CrossrefPubMedGoogle Scholar